Hydroxychloroquine & Pregnancy: Risks, Safety & Medical Guidance
Hydroxychloroquine (HCQ) crosses the placenta and reaches the fetus. While historically used in pregnancy for lupus and malaria, current evidence suggests potential risks.
Potential Risks
- Congenital anomalies: Some studies associate HCQ with cardiac defects.
- Low birth weight: Observed in some cohorts.
- Miscarriage risk: Data are mixed; underlying disease (lupus) also contributes.
Current Recommendations
- Do not start HCQ during pregnancy unless benefits clearly outweigh risks.
- If already taking HCQ and become pregnant: Do not stop abruptly. Consult your rheumatologist and OB/GYN immediately. Continuation may be advised for disease control (especially lupus), as flare risks may exceed drug risks.
- Regular fetal monitoring (ultrasounds, echocardiograms) is recommended.
Bottom Line
Decisions must be individualized. Never adjust medication without specialist guidance.
Pregnancy & Health - Related Articles
- Alcohol in Early Pregnancy: Risks, Evidence, and Clinical Guidance
- Staffy Pregnancy Length: Average Gestation & Timeline
- Birth Control & Acne: What Happens When You Stop?
- Lortab (Hydrocodone/Acetaminophen) in Pregnancy: Risks and Safety Classification
- Best Time to Take a Pregnancy Test: First Morning Urine Explained
- Pregnancy and Illness: Understanding Immune System Changes
- When to Take a Pregnancy Test After Giving Birth: Avoiding False Positives
